HGHRX Mutual Fund

NAV$42.33

Returns Overview

1 Month
+7.69%
3 Months
+10.94%
6 Months
+5.20%
YTD
+4.88%
1 Year
+32.46%
3 Years (annualized)
+8.36%
5 Years (annualized)
+5.10%
10 Years (annualized)
+13.00%

Risk Metrics (1-Year)

No risk data available for this Mutual Fund

Stress Test Scenarios

How would HGHRX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

Loading chart data...

3 Months Performance

Loading chart data...

6 Months Performance

Loading chart data...

1 Year Performance

Loading chart data...

Benchmark & Peers

Benchmark
S&P Composite 1500 Health Care(^SP1500-35:SP)
This Mutual Fund (YTD)
+4.88%
Peer Avg (YTD)
+7.57%
vs Peers
-2.69%

HGHRX Mutual Fund Performance

HGHRX performance across multiple time periods: 1-month 7.69%, YTD 4.88%, 1-year 32.46%, 3-year 8.36%, 5-year 5.10%, 10-year 13.00%.

HGHRX returns trail the peer average of 7.57% YTD. With an expense ratio of 1.63%, investors should weigh costs against performance when evaluating this mutual fund.

HGHRX performance comparison shows side-by-side returns with another fund. HGHRX alternatives are available in the Mutual Fund Screener.